Virginia Retirement Systems Et Al Ultragenyx Pharmaceutical Inc. Transaction History
Virginia Retirement Systems Et Al
- $10.1 Billion
- Q3 2023
A detailed history of Virginia Retirement Systems Et Al transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 14,300 shares of RARE stock, worth $585,728. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,300
Previous 10,800
32.41%
Holding current value
$585,728
Previous $498,000
2.21%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RARE
# of Institutions
286Shares Held
78.6MCall Options Held
570KPut Options Held
228K-
Vanguard Group Inc Valley Forge, PA8.7MShares$356 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.09MShares$290 Million5.31% of portfolio
-
Black Rock Inc. New York, NY5.24MShares$214 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.1MShares$168 Million0.03% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.86MShares$158 Million0.53% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.87B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...